Product: Substance P Antibody
Catalog: DF7522
Description: Rabbit polyclonal antibody to Substance P
Application: WB IHC IF/ICC
Reactivity: Human, Mouse, Rat
Prediction: Bovine, Horse, Sheep, Rabbit, Dog, Chicken
Mol.Wt.: 16kDa; 15kD(Calculated).
Uniprot: P20366
RRID: AB_2841021

View similar products>>

   Size Price Inventory
 100ul $280 In stock
 200ul $350 In stock

Lead Time: Same day delivery

For pricing and ordering contact:
Local distributors

Product Info

Source:
Rabbit
Application:
WB 1:1000-3000, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

Reactivity:
Human,Mouse,Rat
Prediction:
Bovine(100%), Horse(100%), Sheep(100%), Rabbit(100%), Dog(100%), Chicken(88%)
Clonality:
Polyclonal
Specificity:
Substance P Antibody detects endogenous levels of total Substance P.
RRID:
AB_2841021
Cite Format: Affinity Biosciences Cat# DF7522, RRID:AB_2841021.
Conjugate:
Unconjugated.
Purification:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
Storage:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
Alias:

Fold/Unfold

C-terminal-flanking peptide; neurokinin A; neurokinin alpha; NKA; NKNA; PPT; preprotachykinin; protachykinin; protachykinin-1; SubstanceP; TAC1; TAC2; Tachykinin 1; Tachykinin precursor 1; Tachykinin1; TKN1_HUMAN; SP;

Immunogens

Immunogen:
Uniprot:
Gene(ID):
Sequence:
MKILVALAVFFLVSTQLFAEEIGANDDLNYWSDWYDSDQIKEELPEPFEHLLQRIARRPKPQQFFGLMGKRDADSSIEKQVALLKALYGHGQISHKRHKTDSFVGLMGKRALNSVAYERSAMQNYERRR

Predictions

Predictions:

Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.

Species
Results
Score
Horse
100
Bovine
100
Sheep
100
Dog
100
Rabbit
100
Chicken
88
Xenopus
63
Zebrafish
63
Pig
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

Research Backgrounds

Function:

Tachykinins are active peptides which excite neurons, evoke behavioral responses, are potent vasodilators and secretagogues, and contract (directly or indirectly) many smooth muscles.

PTMs:

The substance P form is cleaved at Pro-59 by the prolyl endopeptidase FAP (seprase) activity (in vitro).

Subcellular Location:

Secreted.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
Family&Domains:

Belongs to the tachykinin family.

References

1). Terrestrosin D ameliorates skin lesions in an imiquimod-induced psoriasis-like murine model by inhibiting the interaction between Substance P and Dendritic cells. PHYTOMEDICINE, 2022 (PubMed: 34923236) [IF=6.7]

2). Targeting NK-1R attenuates renal fibrosis via modulating inflammatory responses and cell fate in chronic kidney disease. Frontiers in Immunology, 2023 (PubMed: 37033943) [IF=5.7]

3). The Effect of Shaoyao Gancao Decoction on Sphincter of Oddi Dysfunction in Hypercholesterolemic Rabbits via Protecting the Enteric Nervous System–Interstitial Cells of Cajal–Smooth Muscle Cells Network. Journal of Inflammation Research, 2021 (PubMed: 34552344) [IF=4.5]

4). Zhiqiao Gancao decoction regulated JAK2/STAT3/ macrophage M1 polarization to ameliorate intervertebral disc degeneration. Heliyon, 2024 (PubMed: 39170327) [IF=4.0]

Application: WB    Species: Rat    Sample:

Fig. 2 The impact of ZQGCD on IDD rats. (A) Paw withdrawal threshold in rats. (B) Paw withdrawal latency in rats. (C) Relative expression level of substance P protein in intervertebral disc tissue of rats. The unedited images are referenced in Fig. S1 (D) Representative HE-stained intervertebral disc sections (magnification: 10 × or 40 × ). (E) Intervertebral disc histopathologic score. *: P < 0.05, **: P < 0.01, ***: P < 0.001, ****: P < 0.0001, ns: P>0.05.

5). Clinical and Animal Studies of Waist and Knee Scraping Therapy for Knee Osteoarthritis. Combinatorial chemistry & high throughput screening, 2024 (PubMed: 38284729) [IF=1.6]

6). Acupuncture Needling, Electroacupuncture, and Fire Needling Improve Imiquimod-Induced Psoriasis-Like Skin Lesions through Reducing Local Inflammatory Responses. Evidence-based Complementary and Alternative Medicine, 2019 (PubMed: 31467575)

Application: WB    Species: mouse    Sample: skin

Figure 5: | Acupuncture needling and electroacupuncture reduced the expression levels of Neurokinin A (NKA) in IMQ-induced mouse skin lesions. Te expression levels of (a) NKA, and (b) Substance P (SP) were detected by Western immunoblotting. Data are presented as the mean ± SD (n = 7/group). ##p<0.01, ###p<0.001 vs Ctrl; ∗p <0.05, ∗∗p <0.01 vs model.

7). Electroacupuncture Modulates 5-HT4R-Mediated cAMP/PKA Signaling to Improve Intestinal Motility Disorders in a Thy1- α Syn Parkinson's Mouse Model. Evidence-based complementary and alternative medicine : eCAM, 2022 (PubMed: 36337584)

Application: WB    Species: Mouse    Sample: colon tissue

Figure 4 Effects of electroacupuncture on the expression of SP and CGRP neurotransmitters in the colon tissue of Thy1-αSyn transgenic mice. (a) mRNA expression of SP. (b) mRNA expression of CGRP. (c) Representative western blot images showing the protein expression levels of SP and CGRP. (d) Protein expression in the mouse colon tissue of the normal control (N), PD model (M), electroacupuncture (EA), and western medicine (WM) groups. ∗P < 0.05 and ∗∗P < 0.01 relative to the normal control group; #P < 0.05 and ##P < 0.01 relative to the PD model group.

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.